Expression Profile of miRs in Mesial Temporal Lobe Epilepsy: Systematic Review
- PMID: 35055144
- PMCID: PMC8781102
- DOI: 10.3390/ijms23020951
Expression Profile of miRs in Mesial Temporal Lobe Epilepsy: Systematic Review
Abstract
Temporal lobe epilepsy (TLE) is one of the most common forms of focal epilepsy in children and adults. TLE is characterized by variable onset and seizures. Moreover, this form of epilepsy is often resistant to pharmacotherapy. The search for new mechanisms for the development of TLE may provide us with a key to the development of new diagnostic methods and a personalized approach to the treatment. In recent years, the role of non-coding ribonucleic acids (RNA) has been actively studied, among which microRNA (miR) is of the greatest interest. (1) Background: The purpose of the systematic review is to analyze the studies carried out on the role of miRs in the development of mesial TLE (mTLE) and update the existing knowledge about the biomarkers of this disease. (2) Methods: The search for publications was carried out in the databases PubMed, Springer, Web of Science, Clinicalkeys, Scopus, OxfordPress, Cochrane. The search was carried out using keywords and combinations. We analyzed publications for 2016-2021, including original studies in an animal model of TLE and with the participation of patients with TLE, thematic and systemic reviews, and Cochrane reviews. (3) Results: this thematic review showed that miR‒155, miR‒153, miR‒361‒5p, miR‒4668‒5p, miR‒8071, miR‒197‒5p, miR‒145, miR‒181, miR‒199a, miR‒1183, miR‒129‒2‒3p, miR‒143‒3p (upregulation), miR-134, miR‒0067835, and miR‒153 (downregulation) can be considered as biomarkers of mTLE. However, the roles of miR‒146a, miR‒142, miR‒106b, and miR‒223 are questionable and need further study. (4) Conclusion: In the future, it will be possible to consider previously studied miRs, which have high specificity and sensitivity in mTLE, as prognostic biomarkers (predictors) of the risk of developing this disease in patients with potentially epileptogenic structural damage to the mesial regions of the temporal lobe of the brain (congenital disorders of the neuronal migration and neurogenesis, brain injury, neuro-inflammation, tumor, impaired blood supply, neurodegeneration, etc.).
Keywords: biomarker; diagnostic panel; epilepsy; epileptogenesis; genetics; microRNA; seizure; temporal lobe epilepsy; therapeutic resistance.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
MicroRNAs as Biomarkers of Surgical Outcome in Mesial Temporal Lobe Epilepsy: A Systematic Review.Int J Mol Sci. 2023 Mar 16;24(6):5694. doi: 10.3390/ijms24065694. Int J Mol Sci. 2023. PMID: 36982768 Free PMC article.
-
Mass Spectrometry as a Quantitative Proteomic Analysis Tool for the Search for Temporal Lobe Epilepsy Biomarkers: A Systematic Review.Int J Mol Sci. 2023 Jul 5;24(13):11130. doi: 10.3390/ijms241311130. Int J Mol Sci. 2023. PMID: 37446307 Free PMC article.
-
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD001031. doi: 10.1002/14651858.CD001031.pub4. Cochrane Database Syst Rev. 2018. PMID: 29952431 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Treatments for seizures in catamenial (menstrual-related) epilepsy.Cochrane Database Syst Rev. 2021 Sep 16;9(9):CD013225. doi: 10.1002/14651858.CD013225.pub3. Cochrane Database Syst Rev. 2021. PMID: 34528245 Free PMC article.
Cited by
-
Circulating miRNAs as Novel Clinical Biomarkers in Temporal Lobe Epilepsy.Noncoding RNA. 2024 Mar 17;10(2):18. doi: 10.3390/ncrna10020018. Noncoding RNA. 2024. PMID: 38525737 Free PMC article. Review.
-
MicroRNA: A Linking between Astrocyte Dysfunction, Mild Cognitive Impairment, and Neurodegenerative Diseases.Life (Basel). 2022 Sep 16;12(9):1439. doi: 10.3390/life12091439. Life (Basel). 2022. PMID: 36143475 Free PMC article. Review.
-
Preliminary Evidence for Neuronal Dysfunction Following Adverse Childhood Experiences: An Investigation of Salivary MicroRNA Within a High-Risk Youth Sample.Genes (Basel). 2024 Nov 4;15(11):1433. doi: 10.3390/genes15111433. Genes (Basel). 2024. PMID: 39596633 Free PMC article.
-
MicroRNAs as Biomarkers of Surgical Outcome in Mesial Temporal Lobe Epilepsy: A Systematic Review.Int J Mol Sci. 2023 Mar 16;24(6):5694. doi: 10.3390/ijms24065694. Int J Mol Sci. 2023. PMID: 36982768 Free PMC article.
-
Biomarkers of Drug Resistance in Temporal Lobe Epilepsy in Adults.Metabolites. 2023 Jan 4;13(1):83. doi: 10.3390/metabo13010083. Metabolites. 2023. PMID: 36677008 Free PMC article.
References
-
- Nayak C.S., Bandyopadhyay S. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2021. Mesial Temporal Lobe Epilepsy; p. 26. - PubMed
-
- Karlov V.A. Epilepsy in Children and Adult’s Females and Males: Manual for the Physician. 2nd ed. Binom; Moscow, Russia: 2019. p. 893.
-
- Narodova E.A., Narodov A.A., Shnayder N.A., Dmitrenko D.V., Strotskaya I.G. Current approaches to neurosurgical treatment for drug-resistant focal epilepsy in adults. Neurol. Neuropsychiatry Psychosom. 2018;10:81–88. doi: 10.14412/2074-2711-2018-1S-81-88. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources